Can premium deficiencies in one group offset profits in other groups?

Prepare for the CAS Exam 6 with detailed study materials. Use flashcards and multiple-choice questions, each with hints and explanations, to get exam-ready!

Multiple Choice

Can premium deficiencies in one group offset profits in other groups?

Premium deficiency testing evaluates whether future premiums are adequate to cover the expected future benefits and expenses for each group separately. If a group is projected to have a deficiency, that shortfall must be funded for that group itself and cannot be absorbed by profits from other groups. The idea is to keep solvency and pricing discipline at the level of each group, preventing cross-subsidization across groups from masking risks in one area with gains in another. In practice, if a group shows a premium deficiency, you would address it with appropriate reserves, adjustments to pricing, or additional capital dedicated to that group, rather than netting against better results elsewhere. The existence of a deficiency is a signal that that specific line of business may need to be priced more accurately or funded more robustly. Regulator approval is not what allows cross-group offsetting in this context, and interrelation of groups doesn’t change the fact that each group’s deficiency is handled on its own merits.

Premium deficiency testing evaluates whether future premiums are adequate to cover the expected future benefits and expenses for each group separately. If a group is projected to have a deficiency, that shortfall must be funded for that group itself and cannot be absorbed by profits from other groups. The idea is to keep solvency and pricing discipline at the level of each group, preventing cross-subsidization across groups from masking risks in one area with gains in another.

In practice, if a group shows a premium deficiency, you would address it with appropriate reserves, adjustments to pricing, or additional capital dedicated to that group, rather than netting against better results elsewhere. The existence of a deficiency is a signal that that specific line of business may need to be priced more accurately or funded more robustly.

Regulator approval is not what allows cross-group offsetting in this context, and interrelation of groups doesn’t change the fact that each group’s deficiency is handled on its own merits.

More practice questions